BSE filing, NSE: TANLA. Summary written from the filing by ALFA Finder's alert engine.
Tanla Platforms Ltd: key numbers
- Share price
- ₹597.60
- Market cap
- ₹7,926 Cr
- Revenue (annual)
- ₹4,418 Cr
- Net profit (annual)
- ₹509.1 Cr
- P/E (TTM)
- 14.3×Sector 23.0×
- Promoter holding
- 46.17%+0.00% QoQ
- FII holding
- 8.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tanla Platforms Ltd
All →Tanla Platforms Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹13,517 Mn (+25.3% YoY), EBITDA ₹2,143 Mn (+20.8%), PAT ₹1,464 Mn (+17.1%). Debt-free, cash ₹14,474 Mn, ROCE 27%.
Tanla Platforms Results Update
Tanla reported Q2 FY27 revenue of ₹1,352 Cr, up 25.3% YoY, and PAT of ₹146 Cr. The update came via press release, not a full results statement.
Tanla Platforms Dividend
Tanla Platforms declared a first interim dividend of Rs 6 per equity share for FY 2026-27. The record date for entitlement is 02 November 2026.
Tanla Platforms Q2 FY27 Results: Net Profit ₹146.4 Cr, Up 17.1% YoY
Tanla Platforms Ltd reported revenue from operations of ₹1,352 Cr (+25.3% YoY) and net profit of ₹146.4 Cr (+17.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹146.4 Cr · +17.1% YoY
Tanla Platforms Board Meeting Date
Tanla Platforms will hold a board meeting on October 27, 2026, to consider unaudited financial results and a potential interim dividend.
Tanla Platforms Employee Stock Options
Tanla Platforms allotted 16,665 equity shares under its RSU 2021 plan and transferred 36,300 shares under its TPL Stock Options Scheme 2024.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.